You are here

Article info

Article menu
Download PDFPDF
Multiple sclerosis
Research paper
MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance

Authors

  • Martijn T Wijburg Department of Neurology, Amsterdam Neuroscience, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands Department of Radiology & Nuclear Medicine, Amsterdam Neuroscience, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Birgit I Witte Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Anke Vennegoor Department of Neurology, Amsterdam Neuroscience, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Stefan D Roosendaal Department of Radiology & Nuclear Medicine, Amsterdam Neuroscience, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands Department of Radiology, Academic Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Esther Sanchez Department of Radiology & Nuclear Medicine, Amsterdam Neuroscience, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Yaou Liu Department of Radiology & Nuclear Medicine, Amsterdam Neuroscience, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands Department of Radiology, Xuanwu Hospital, Capital Medical University, Beijing, P. R. China PubMed articlesGoogle scholar articles
  • Carine O Martins Jarnalo Department of Radiology & Nuclear Medicine, Amsterdam Neuroscience, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands Department of Radiology, Albert Schweitzer Hospital, Dordrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Bernard MJ Uitdehaag Department of Neurology, Amsterdam Neuroscience, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Frederik Barkhof Department of Radiology & Nuclear Medicine, Amsterdam Neuroscience, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Joep Killestein Department of Neurology, Amsterdam Neuroscience, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Mike P Wattjes Department of Radiology & Nuclear Medicine, Amsterdam Neuroscience, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Martijn T Wijburg, Department of Neurology, Neuroscience Amsterdam, VUmc MS center Amsterdam, VU University Medical Center, De Boelelaan 1117, Amsterdam 1081 HV, The Netherlands; m.wijburg{at}vumc.nl
View Full Text

Citation

Wijburg MT, Witte BI, Vennegoor A, et al
MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance
Journal of Neurology, Neurosurgery & Psychiatry 2016;87:1138-1145.

Publication history

  • Received April 13, 2016
  • Revised July 4, 2016
  • Accepted July 8, 2016
  • First published August 16, 2016.
Online issue publication 
September 13, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/